Literature DB >> 15147988

The use of antibiotics in the diabetic foot.

Mike Edmonds1, Ali Foster.   

Abstract

Lower limb infections are the most common indication for hospital admission in patients with diabetes. However, diagnosis of infection can be delayed because the normal clinical signs are often absent in patients with diabetes. The proper use of antibiotics in the treatment of the diabetic foot remains contested: one view is to administer antibiotics only in the presence of clinical infection; the other one is to give antibiotics freely to all patients with ulcers. This review of literature includes 2 controlled studies of antibiotics in diabetic foot ulcers. The first study showed no advantage from amoxicillin plus clavulanate as a supplement to standard therapy in uncomplicated ulcers. Patients (N = 44) with neuropathic ulcers (some of whom had cellulitis) were randomized to oral amoxicillin plus clavulanate or matched placebo. At 20 days' follow-up, there was no significant difference in outcome between the 2 groups. A further investigation (N = 64) compared ulcer patients who received oral antibiotics with those who did not. In the group with no antibiotics, 15 patients developed clinical infection, whereas none did in the antibiotic group (P <0.001). Seven patients in the nonantibiotic group needed hospital admission and 3 patients came to amputation. In the nonantibiotic group, 11 of 15 with infection had a positive swab compared with 1 of 17 without infection (P <0.01). In the nonantibiotic group, 17 patients healed, compared with 27 in the antibiotic group (P <0.02), with significantly more ischemic patients healing in the antibiotic group (P <0.01). Patients with diabetes who have clean ulcers associated with peripheral vascular disease and positive ulcer swabs should be considered for early antibiotic treatment. The diabetic foot is highly susceptible to repeat ulceration, and diabetic ulcers are more prone to infection than other ulcers. Furthermore, untreated infection can lead to amputation. This cycle can be broken only with aggressive treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147988     DOI: 10.1016/S0002-9610(03)00300-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  14 in total

1.  The effect of hyaluronan combined with KI3 complex (Hyiodine wound dressing) on keratinocytes and immune cells.

Authors:  Jana Frankova; Lukas Kubala; Vladimir Velebny; Milan Ciz; Antonin Lojek
Journal:  J Mater Sci Mater Med       Date:  2006-10       Impact factor: 3.896

2.  Letter: microbiological and clinical mismanagement of non healing diabetic leg ulcers?

Authors:  Adenike Ao Ogunshe
Journal:  Int Wound J       Date:  2011-08-09       Impact factor: 3.315

Review 3.  Choice of wound care in diabetic foot ulcer: A practical approach.

Authors:  Karakkattu Vijayan Kavitha; Shalbha Tiwari; Vedavati Bharat Purandare; Sudam Khedkar; Shilpa Sameer Bhosale; Ambika Gopalakrishnan Unnikrishnan
Journal:  World J Diabetes       Date:  2014-08-15

4.  Diabetic foot ulcers: practical treatment recommendations.

Authors:  Michael Edmonds
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Validating the probe-to-bone test and other tests for diagnosing chronic osteomyelitis in the diabetic foot.

Authors:  Rosario Morales Lozano; Maria L González Fernández; David Martinez Hernández; Juan V Beneit Montesinos; Sagrario Guisado Jiménez; Maximo A Gonzalez Jurado
Journal:  Diabetes Care       Date:  2010-07-09       Impact factor: 19.112

Review 6.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.

Authors:  A Jeandrot; J-L Richard; C Combescure; N Jourdan; S Finge; M Rodier; P Corbeau; A Sotto; J-P Lavigne
Journal:  Diabetologia       Date:  2007-10-13       Impact factor: 10.122

8.  [Bacteriological profile of diabetic foot and its impact on the choice of antibiotics].

Authors:  Adil Zemmouri; Mohamed Tarchouli; Abdellatif Benbouha; Tarik Lamkinsi; Mustapha Bensghir; Mostafa Elouennass; Cherqui Haimeur
Journal:  Pan Afr Med J       Date:  2015-02-17

9.  One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers.

Authors:  Karen Smith; Andrew Collier; Eleanor M Townsend; Lindsay E O'Donnell; Abhijit M Bal; John Butcher; William G Mackay; Gordon Ramage; Craig Williams
Journal:  BMC Microbiol       Date:  2016-03-22       Impact factor: 3.605

10.  Can We Stop Antibiotic Therapy When Signs and Symptoms Have Resolved in Diabetic Foot Infection Patients?

Authors:  Yuejie Chu; Chao Wang; Jinghang Zhang; Penghua Wang; Jun Xu; Min Ding; Xiwen Li; Xiaoli Hou; Shuhong Feng; Xuemei Li
Journal:  Int J Low Extrem Wounds       Date:  2015-08-06       Impact factor: 2.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.